Notice: This company has been marked as potentially delisted and may not be actively trading. Nuwellis (CHFS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends CHFS vs. OM, POCI, IRIX, PTHL, BSGM, MOVE, NRXS, QTI, STRR, and PXDTShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Outset Medical (OM), Precision Optics (POCI), IRIDEX (IRIX), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), BioSig Technologies (BSGM), Movano (MOVE), NeurAxis (NRXS), QT Imaging (QTI), Star Equity (STRR), and Pixie Dust Technologies (PXDT). Nuwellis vs. Outset Medical Precision Optics IRIDEX Pheton Holdings Ltd Class A Ordinary Shares BioSig Technologies Movano NeurAxis QT Imaging Star Equity Pixie Dust Technologies Nuwellis (NASDAQ:CHFS) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, community ranking, institutional ownership, earnings, profitability and risk. Do analysts prefer CHFS or OM? Outset Medical has a consensus price target of $4.70, indicating a potential upside of 493.51%. Given Outset Medical's stronger consensus rating and higher probable upside, analysts clearly believe Outset Medical is more favorable than Nuwellis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuwellis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Outset Medical 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has preferable earnings and valuation, CHFS or OM? Nuwellis has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuwellis$5.51M1.97-$18.11M-$279.28-0.01Outset Medical$130.38M0.32-$172.80M-$2.76-0.29 Which has more volatility and risk, CHFS or OM? Nuwellis has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Comparatively, Outset Medical has a beta of 1.95, meaning that its share price is 95% more volatile than the S&P 500. Does the media prefer CHFS or OM? In the previous week, Outset Medical had 3 more articles in the media than Nuwellis. MarketBeat recorded 3 mentions for Outset Medical and 0 mentions for Nuwellis. Outset Medical's average media sentiment score of 0.51 beat Nuwellis' score of 0.00 indicating that Outset Medical is being referred to more favorably in the news media. Company Overall Sentiment Nuwellis Neutral Outset Medical Positive Do institutionals & insiders believe in CHFS or OM? 65.1% of Nuwellis shares are held by institutional investors. 0.6% of Nuwellis shares are held by insiders. Comparatively, 3.5% of Outset Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is CHFS or OM more profitable? Outset Medical has a net margin of -122.84% compared to Nuwellis' net margin of -254.26%. Outset Medical's return on equity of -164.92% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Nuwellis-254.26% -173.61% -131.01% Outset Medical -122.84%-164.92%-43.27% Does the MarketBeat Community believe in CHFS or OM? Nuwellis received 300 more outperform votes than Outset Medical when rated by MarketBeat users. Likewise, 69.53% of users gave Nuwellis an outperform vote while only 39.34% of users gave Outset Medical an outperform vote. CompanyUnderperformOutperformNuwellisOutperform Votes32469.53% Underperform Votes14230.47% Outset MedicalOutperform Votes2439.34% Underperform Votes3760.66% SummaryOutset Medical beats Nuwellis on 12 of the 18 factors compared between the two stocks. Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHFS vs. The Competition Export to ExcelMetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.87M$3.61B$5.16B$8.74BDividend YieldN/A1.65%5.18%4.08%P/E Ratio-0.0412.4868.5613.82Price / Sales1.9796.991,271.8787.50Price / CashN/A46.1739.7135.24Price / Book0.143.806.485.93Net Income-$18.11M$92.21M$119.82M$225.73M Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHFSNuwellisN/A$1.80+1.1%N/A+185.7%$10.87M$5.51M-0.0466Gap UpHigh Trading VolumeOMOutset Medical2.3438 of 5 stars$0.86-4.3%N/A-84.3%$45.23M$130.38M-0.31520POCIPrecision Optics0.9129 of 5 stars$4.73-4.4%N/A-12.1%$30.04M$19.10M-9.6580Short Interest ↓News CoverageGap UpHigh Trading VolumeIRIXIRIDEX0.7217 of 5 stars$1.77-6.3%N/A-15.5%$29.22M$51.87M-2.64120Earnings ReportAnalyst ForecastShort Interest ↓News CoverageHigh Trading VolumePTHLPheton Holdings Ltd Class A Ordinary SharesN/A$4.16-1.4%N/AN/A$27.37MN/A0.0011Positive NewsGap UpBSGMBioSig TechnologiesN/A$1.58-9.7%N/A-48.6%$27.07M$40,000.000.0050News CoverageGap UpMOVEMovano2.2986 of 5 stars$3.52-9.0%N/A-75.0%$23.23M$852,000.00-0.5230Short Interest ↓News CoverageGap UpNRXSNeurAxisN/A$3.27+3.5%N/A+23.0%$22.37M$2.46M-1.7819News CoverageGap UpHigh Trading VolumeQTIQT ImagingN/A$0.49+2.9%N/AN/A$10.48MN/A0.00N/AInsider BuyingShort Interest ↓News CoveragePositive NewsGap UpSTRRStar Equity2.1789 of 5 stars$3.15-2.8%N/A-32.5%$10.17M$45.78M-1.13171Upcoming EarningsNews CoveragePXDTPixie Dust Technologies2.1261 of 5 stars$0.53+18.0%N/A-93.0%$7.90M$6.30M0.0078Short Interest ↑Positive NewsHigh Trading Volume Related Companies and Tools Related Companies OM Alternatives POCI Alternatives IRIX Alternatives PTHL Alternatives BSGM Alternatives MOVE Alternatives NRXS Alternatives QTI Alternatives STRR Alternatives PXDT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CHFS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CHFS Stock Alerts